Product overview
This SKU is a co-lyophilized blend of two of the most-studied connective-tissue research peptides — BPC-157 (10mg) and TB-500 (10mg) — combined in a single 10mg+10mg vial for streamlined bench workflows. Each peptide has been characterized in independent preclinical literature; combining them in a single vial removes one reconstitution step when both molecules are part of the same research protocol.
Independently assayed by HPLC and MS, and lot-traceable to the source preparation.
Typical research dose range
Independent preclinical protocols for the individual peptides typically use BPC-157 in the 200-500 mcg range and TB-500 in the 2-5 mg weekly range in animal models. Combined-vial study designs adapt these ranges to a unified working volume. Researchers should consult source literature for the specific endpoint under investigation.
Reconstitution and storage
Reconstitute each vial with 1-2 mL of bacteriostatic water for the target working concentration. Use sterile technique. Once reconstituted, store at 2-8 °C and use within 30 days for best stability.
Lyophilized vials should be kept refrigerated at 2-8 °C until first use. For long-term storage beyond six months, store at -20 °C in the original sealed vial. Avoid repeated freeze-thaw cycles.
Kit contents
- 10 × co-lyophilized vials of BPC-157 (10mg) + TB-500 (10mg)
- 1 × certificate of analysis (lot-specific)
- 1 × handling and reconstitution insert
